Please assess the completion status of the following clinical trial:

Trial Title: A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male or female subjects 65 years of age or older~* OAB symptoms for at least 3 months~* score 3 or greater on Vulnerable Elderly Survey (VES-13)~* adequate mobility for independent toileting~* mean number of at least 2 UUI episodes per 24 hours~* mean urinary frequency of 8 or more micturitions per 24 hours~* able to independently complete the bladder diaries~Exclusion Criteria:~* PVR urinary volume greater than 200 ml~* MMSE score less than 20~* greater than 15 UUI episodes per 24 hours~* creatinine clearance less than 30 ml/min~* an average resting heart rate of greater than or equal to 90 beats per minute

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fesoterodine (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).